-
Document de presse | 2013.11.04
Two European programs reinforce the fight against emerging diseases
The 31 partners involved in the two major European research programs PREDEMICS and ANTIGONE are to meet for a joint seminar at the Institut Pasteur on November 6th. These two programs will respectively receive €11.7 million and €12 million funding of the European Union over five years to study the emergence mechanisms of infectious diseases in order to strengthen existing treatment and...
-
Document de presse | 2017.05.05
The migration history of Bantu-speaking people: genomics reveals the benefits of admixture and sheds new light on slave trade
During a wave of expansion that began 4,000 to 5,000 years ago, Bantu-speaking populations – today some 310 million people – gradually left their original homeland of West-Central Africa and traveled to the eastern and southern regions of the continent. Using data from a vast genomic analysis of more than 2,000 samples taken from individuals in 57 populations throughout Sub-Saharan Africa,...
-
News | 2020.11.20
Zika outbreaks fostered by virus-permissive mosquitoes
What factors facilitate the emergence of a previously unknown virus in the human population? Scientists from the CNRS, the Institut Pasteur and the IRD, in collaboration with the Institut Pasteur International Network and with several other institutions worldwide, have helped answer that question for the Zika virus. Their study sheds light on regional and continental disparities in Zika...
-
Document de presse | 2022.06.29
Rethinking the rabies vaccine
Rabies virus kills over 50,000 people each year. Although current rabies vaccines are effective, they do not offer lifelong protection and booster doses are required. Institut Pasteur scientists, in collaboration with researchers from La Jolla Institute for Immunology (LJI) in the United States, captured new high-resolution views of rabies virus, revealing potential vaccine targets. These...
-
Document de presse | 2023.06.06
Monkeypox: characterization of post-infectious immune response
In 2022-2023, an outbreak of monkeypox, now known as mpox (caused by the monkeypox virus or MPXV) led to 87,000 human cases in 170 countries[1]. Most cases were reported outside the usual areas in which the virus circulates. Since the outbreak began, surveillance of the virus has been stepped up in Europe, with nearly 5,000 cases being reported in France[2]. Scientists and clinicians from the...
-
News | 2024.03.25
Tackling flaviviruses and preparing the European Union for emerging threats
The genus flavivirus includes several human pathogens, such as Zika, dengue, West Nile virus (WNV) and yellow fever virus, which persist as major threats to global public health. Yellow4FLAVI, coordinated by Giovanna Barba-Spaeth, Institut Pasteur, comprises 13 partner institutions and is supported by the European Union with with € 8 million. The aim is to use the 17D yellow fever vaccine as...
-
Article | 2018.05.28
4-year research group within the Institut Pasteur of São Paulo
This is an international call for applications for young researchers in the life sciences to lead a four-year research group (“G4”) within Institut Pasteur São Paulo
-
Article | 2025.03.10
Assessing ethical acceptability
For any research involving humans or animals, scientists must demonstrate compatibility with applicable ethical standards and legal requirements. At the Institut Pasteur, two bodies assess the ethical dimensions of research protocols: the Committee for Ethics in Animal Experimentation (CETEA) and the Institut Pasteur Institutional Review Board (IRB-IP).
-
News | 2025.07.09
Escherichia coli food poisoning outbreak: update on the epidemiological situation
Since June 6, 2025, the town of Saint-Quentin (in the Aisne département and the Hauts-de-France region) has witnessed cases of severe food poisoning, mostly in children, caused by Escherichia coli bacteria. We look back at the timeline of events, the epidemiological situation and the Institut Pasteur's role in the crisis.
-
Article | 2025.02.20
MD-PhD Program
The Institut Pasteur MD-PhD program is designed to bridge the gap between fundamental, applied research and clinical practice, equipping physicians with the skills needed to tackle the increasingly complex healthcare challenges of today. This program offers opportunities for medical students and doctors to improve patient care and in parallel foster innovation in medical sciences.